Cresset Asset Management, LLC Gilead Sciences, Inc. Transaction History

Cresset Asset Management, LLC

$20.6 Billion
Q1 2024

A detailed history of Cresset Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 95,917 shares of GILD stock, worth $6.39 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

95,917

Previous 95,001 0.96%

Holding current value

$6.39 Million

Previous $7.7 Million 8.72%

% of portfolio

0.03%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $65,567 - $79,957	916 Added 0.96%	95,917 $7.03 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $358,876 - $406,974	4,898 Added 5.44%	95,001 $7.7 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $520,389 - $567,755	-7,038 Reduced 7.25%	90,103 $6.75 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $6 Million - $6.85 Million	78,956 Added 434.18%	97,141 $7.49 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $274,914 - $313,212	-3,556 Reduced 16.36%	18,185 $1.51 Million

Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $57,521 - $82,580	-923 Reduced 4.07%	21,741 $1.87 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $113,364 - $129,491	-1,904 Reduced 7.75%	22,664 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $29,264 - $32,960	-507 Reduced 2.02%	24,568 $1.51 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $892,778 - $1.12 Million	-15,414 Reduced 38.07%	25,075 $1.49 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $6,163 - $6,995	-95 Reduced 0.23%	40,489 $2.94 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $480,192 - $518,074	7,094 Added 21.18%	40,584 $2.84 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $656,724 - $717,564	10,347 Added 44.71%	33,490 $2.31 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $160,740 - $183,404	2,679 Added 13.09%	23,143 $1.5 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $263,535 - $300,286	-4,652 Reduced 18.52%	20,464 $1.19 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $113,208 - $142,339	-1,823 Reduced 6.77%	25,116 $1.59 Million
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $581,251 - $674,940	8,035 Added 42.5%	26,939 $2.07 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $449,933 - $576,300	7,184 Added 61.3%	18,904 $1.41 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $211,294 - $232,417	3,429 Added 41.36%	11,720 $762,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $80,200 - $88,527	1,283 Added 18.31%	8,291 $525,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $223,598 - $250,739	-3,614 Reduced 34.02%	7,008 $473,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $38,205 - $42,800	-611 Reduced 5.44%	10,622 $691,000
Q4 2018 May 21, 2019	BUY	$60.54 - $79.0 $680,045 - $887,407	11,233 New	11,233 $703,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Gilead Sciences, Inc. Transaction History